Lorente, J. S. et al. GPCR drug discovery: new agents, targets and indications. Nat. Rev. Drug Discov. 24, 458–479 (2025).
Rasmussen, S. G. F. et al. Crystal structure of the β2 adrenergic receptor–Gs protein complex. Nature 477, 549–555 (2011).
Kang, Y. et al. Crystal structure of rhodopsin bound to arrestin by femtosecond X-ray laser. Nature 523, 561–567 (2015).
Zhang, Y. et al. Cryo-EM structure of the activated GLP-1 receptor in complex with a G protein. Nature 546, 248–253 (2017).
Liang, Y.-L. et al. Phase-plate cryo-EM structure of a class B GPCR–G-protein complex. Nature 546, 118–123 (2017).
Chen, K. et al. Tail engagement of arrestin at the glucagon receptor. Nature 620, 904–910 (2023).
Shen, C. et al. Structural basis of GABAB receptor–Gi protein coupling. Nature 594, 594–598 (2021).
Mao, C. et al. Cryo-EM structures of inactive and active GABAB receptor. Cell Res. 30, 564–573 (2020).
Wen, T. et al. Molecular basis of β-arrestin coupling to the metabotropic glutamate receptor mGlu3. Nat. Chem. Biol. 21, 1262–1269 (2025).
Hauser, A. S., Attwood, M. M., Rask-Andersen, M., Schiöth, H. B. & Gloriam, D. E. Trends in GPCR drug discovery: new agents, targets and indications. Nat. Rev. Drug Discov. 16, 829–842 (2017).
Thompson, M. D. et al. G protein-coupled receptor (GPCR) gene variants and human genetic disease. Crit. Rev. Clin. Lab. Sci. 61, 317–346 (2024).
Reid, K. M. et al. Loss-of-function variants in DRD1 in infantile parkinsonism-dystonia. Cells 12, 1046 (2023).
Wang, W., Guo, D.-Y. & Tao, Y.-X. Therapeutic strategies for diseases caused by loss-of-function mutations in G protein-coupled receptors. Prog. Mol. Biol. Transl. Sci. 161, 181–210 (2019).
Gaylinn, B. D. et al. The mutant growth hormone-releasing hormone (GHRH) receptor of the little mouse does not bind GHRH. Endocrinology 140, 5066–5074 (1999).
He, J. et al. ASD2023: towards the integrating landscapes of allosteric knowledgebase. Nucleic Acids Res. 52, D376–D383 (2024).
Koole, C. et al. Polymorphism and ligand dependent changes in human glucagon-like peptide-1 receptor (GLP-1R) function: allosteric rescue of loss of function mutation. Mol. Pharmacol. 80, 486–497 (2011).
Leach, K. et al. Impact of clinically relevant mutations on the pharmacoregulation and signaling bias of the calcium-sensing receptor by positive and negative allosteric modulators. Endocrinology 154, 1105–1116 (2013).
Cong, Z. et al. Molecular insights into ago-allosteric modulation of the human glucagon-like peptide-1 receptor. Nat. Commun. 12, 3763 (2021).
Kumar, K. K. et al. Negative allosteric modulation of the glucagon receptor by RAMP2. Cell 186, 1465–1477 (2023).
Chen, H., Qin, Y., Chou, M., Cyster, J. G. & Li, X. Transmembrane protein CD69 acts as an S1PR1 agonist. eLife 12, e88204 (2023).
Luo, P. et al. Structural basis of signaling regulation of the human melanocortin-2 receptor by MRAP1. Cell Res. 33, 46–54 (2023).
Liang, Y.-L. et al. Cryo-EM structure of the active, Gs-protein complexed, human CGRP receptor. Nature 561, 492–497 (2018).
Cao, J. et al. A structural basis for amylin receptor phenotype. Science 375, 1371 (2022).
Liang, Y.-L. et al. Structure and dynamics of adrenomedullin receptors AM1 and AM2 reveal key mechanisms in the control of receptor phenotype by receptor activity-modifying proteins. ACS Pharmacol. Transl. Sci. 3, 263–284 (2020).
Zhang, J. et al. Predicting protein-protein interactions in the human proteome. Science 390, 353 (2025).
Balbi, P. E. M. et al. Mapping targetable sites on the human surfaceome for the design of novel binders. Preprint at bioRxiv https://doi.org/10.1101/2024.12.16.628626 (2024).
Yin, H. et al. Computational design of peptides that target transmembrane helices. Science 315, 1817–1822 (2007).
Mravic, M. et al. De novo designed transmembrane peptides activating the α5β1 integrin. Protein Eng. Des. Sel. 31, 181–190 (2018).
Mravic, M. et al. De novo-designed transmembrane proteins bind and regulate a cytokine receptor. Nat. Chem. Biol. 20, 751–760 (2024).
Bennett, N. R. et al. Improving de novo protein binder design with deep learning. Nat. Commun. 14, 2625 (2023).
Frank, C. et al. Scalable protein design using optimization in a relaxed sequence space. Science 386, 439–445 (2024).
Pacesa, M. et al. One-shot design of functional protein binders with BindCraft. Nature 646, 483–492 (2025).
Huang, B. et al. Designed endocytosis-inducing proteins degrade targets and amplify signals. Nature 638, 796–804 (2024).
Glögl, M. et al. Target-conditioned diffusion generates potent TNFR superfamily antagonists and agonists. Science 386, 1154–1161 (2024).
Duart, G. et al. Computational design of BclxL inhibitors that target transmembrane domain interactions. Proc. Natl Acad. Sci. USA 120, e2219648120 (2023).
Anishchenko, I. et al. De novo protein design by deep network hallucination. Nature 600, 547–552 (2021).
Jumper, J. et al. Highly accurate protein structure prediction with AlphaFold. Nature 596, 583–589 (2021).
Abramson, J. et al. Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature 630, 493–500 (2024).
Dauparas, J. et al. Robust deep learning–based protein sequence design using ProteinMPNN. Science 378, 49–56 (2022).
Kortemme, T. De novo protein design—From new structures to programmable functions. Cell 187, 526–544 (2024).
Evans, R. et al. Protein complex prediction with AlphaFold-Multimer. Preprint at bioRxiv https://doi.org/10.1101/2021.10.04.463034 (2021).
Goverde, C. A. et al. Computational design of soluble and functional membrane protein analogues. Nature 631, 449–458 (2024).
Roney, J. P. & Ovchinnikov, S. State-of-the-art estimation of protein model accuracy using AlphaFold. Phys. Rev. Lett. 129, 238101 (2022).
Yim, J. et al. SE(3) diffusion model with application to protein backbone generation. In Proc. 40th International Conference on Machine Learning 40001–40039 (JMLR.org, 2023).
Watson, J. L. et al. De novo design of protein structure and function with RFdiffusion. Nature 620, 1089–1100 (2023).
Sahoo, P. et al. A systematic survey of prompt engineering in large language models: techniques and applications. Preprint at https://doi.org/10.48550/arXiv.2402.07927 (2024).
Heo, L. & Feig, M. Multi-state modeling of G-protein coupled receptors at experimental accuracy. Proteins 90, 1873–1885 (2022).
Chun, E. et al. Fusion partner toolchest for the stabilization and crystallization of G protein-coupled receptors. Structure 20, 967–976 (2012).
Zhang, K., Wu, H., Hoppe, N., Manglik, A. & Cheng, Y. Fusion protein strategies for cryo-EM study of G protein-coupled receptors. Nat. Commun. 13, 4366 (2022).
Schöneberg, T. & Liebscher, I. Mutations in G protein–coupled receptors: mechanisms, pathophysiology and potential therapeutic approaches. Pharmacol. Rev. 73, 89–119 (2021).
Kooistra, A. J. et al. GPCRdb in 2021: integrating GPCR sequence, structure and function. Nucleic Acids Res. 49, D335–D343 (2021).
Zhang, H. et al. Structural insights into ligand recognition and activation of the melanocortin-4 receptor. Cell Res. 31, 1163–1175 (2021).
Gray, D. L. et al. Impaired β-arrestin recruitment and reduced desensitization by non-catechol agonists of the D1 dopamine receptor. Nat. Commun. 9, 674 (2018).
Wu, C. et al. Pharmacological characterization of dopamine receptor DRD1 variants and exploration of their allosteric activation. Biochemistry 64, 2200–2211 (2025).
Schweke, H. et al. An atlas of protein homo-oligomerization across domains of life. Cell 187, 999–1010 (2024).
Tunyasuvunakool, K. et al. Highly accurate protein structure prediction for the human proteome. Nature 596, 590–596 (2021).
Pettersen, E. F. et al. UCSF ChimeraX: Structure visualization for researchers, educators, and developers. Protein Sci. 30, 70–82 (2021).
Mirdita, M. et al. ColabFold: making protein folding accessible to all. Nat. Methods 19, 679–682 (2022).
Zhuang, Y. et al. Mechanism of dopamine binding and allosteric modulation of the human D1 dopamine receptor. Cell Res. 31, 593–596 (2021).
Crooks, G. E., Hon, G., Chandonia, J.-M. & Brenner, S. E. WebLogo: a sequence logo generator. Genome Res. 14, 1188–1190 (2004).
Hunter, J. D. Matplotlib: a 2D graphics environment. Comput. Sci. Eng. 9, 90–95 (2007).
Zhuang, Y. et al. Structural insights into the human D1 and D2 dopamine receptor signaling complexes. Cell 184, 931–942 (2021).
Zivanov, J. et al. A Bayesian approach to single-particle electron cryo-tomography in RELION-4.0. eLife 11, e83724 (2022).
Punjani, A., Zhang, H. & Fleet, D. J. Non-uniform refinement: adaptive regularization improves single-particle cryo-EM reconstruction. Nat. Methods 17, 1214–1221 (2020).
Teng, X. et al. Structural insights into G protein activation by D1 dopamine receptor. Sci. Adv. 8, eabo4158 (2022).
Pettersen, E. F. et al. UCSF Chimera—a visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605–1612 (2004).
Moriarty, N. W., Grosse-Kunstleve, R. W. & Adams, P. D. Electronic ligand builder and optimization workbench (eLBOW): a tool for ligand coordinate and restraint generation. Acta Crystallogr. D 65, 1074–1080 (2009).
Leaver-Fay, A. et al. Rosetta3: an object-oriented software suite for the simulation and design of macromolecules. Methods Enzymol. 487, 545–574 (2011).
Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. D. 66, 486–501 (2010).
Afonine, P. V. et al. Real-space refinement in Phenix for cryo-EM and crystallography. Acta Crystallogr. D 74, 531–544 (2018).
Afonine, P. V. et al. New tools for the analysis and validation of cryo-EM maps and atomic models. Acta Crystallogr. D 74, 814–840 (2018).
He, Y., Jin, W.-Q., Shen, Q.-X., Chen, X.-J. & Jin, G.-Z. Expression of dopamine D1 receptor in Sf9 insect cells and agonism of l-12-chloroscoulerine on recombinant D1 receptor. Acta Pharmacol. Sin. 24, 225–229 (2003).
